Clasado to release Food Matters Live podcast

Clasado Biosciences (‘Clasado’), a global leader in the development of clinically proven prebiotic ingredient and product solutions for the human gut microbiome, has recorded a new podcast, ‘The role of the gut microbiome in immune health’ as part of the recently announced Food Matters Live Digital event.

Podcast guests include Lecturers from the Universities of Reading and Southampton, Dr Gemma Walton and Dr Caroline Childs, as well as Dr Lucien Harthoorn, Research and Development Director at Clasado. The podcast will air on June 18 and will be made available on the Clasado website as well as podcast platforms such as Google Podcasts, Apple iTunes and Spotify.

Dr Lucien Harthoorn commented: “The Covid-19 pandemic has put a renewed consumer focus on immune health. Around 70% of immune cells reside in the gut, which makes it a fascinating area of research and development.” 

After an introduction to the gut microbiome and factors that influence its development throughout the human lifespan, the podcast covers a number of important fields in contemporary gut health and wellness. Discussing the gut-immune axis – the complex interplay the gut has with the immune system – as well as the scientific principles guiding the development of today’s prebiotic supplements, the podcast answers some of the key questions posed by consumers and healthcare professionals today.

The podcast takes a particularly close look at the impact of diet on gut health, as well as the role of supplementation in modulating the gut microbiome and immunity. The podcast outlines a number of important studies that note the effect of GOS on natural killer cells and immune markers such as Interleukin-10 and Interleukin-6 in diverse demographics, including research from the University of Reading and the University of Oslo. 

Further studies discussed include a 2016 study by Dr Neil Williams of Nottingham Trent University, that found in a study of those with exercise-induced bronchoconstriction, a phenotype of asthma, that the supplement form of prebiotic Bimuno® improved respiratory function and diminished Th2 driven inflammatory markers.

Dr Harthoorn continued: “We are delighted to be joined by Dr Walton and Dr Childs on this journey – both have leading knowledge in gut microbiome and nutritional sciences. Consumers and healthcare professionals alike are looking for clarity on the topic and insight to the products available on the market today. Our podcast will discuss the current understanding of the gut’s role in immune health and how this is supported by numerous studies. This will be contextualised using our first-hand experience from the development of Bimuno®.”